Dr. Anna Nikolaidou is a physician and PhD candidate in experimental medicine at the Institute for Ophthalmic Research, University of Tübingen, where her work focuses on myopia, electrophysiology, and pediatric neuro-ophthalmology. She holds an MD along with two MSc degrees, in medical research methodology and in nanomedicine. Her research spans pediatric ophthalmology, ranging from AI-based diagnostic tools to the ocular effects of autoimmune disease in children, with findings published in prestigious journals including Eye and Pharmaceuticals. She received multiple grants to present at meetings such as the International Society for Clinical Electrophysiology of Vision (ISCEV, 2026) meeting and the Association for Research in Vision and Ophthalmology (ARVO, 2026) meetings.
The authors of a review of 16 gene therapy trials for inherited retinal diseases explain why the pediatric evidence base remains thin and argue that individual-level, age-stratified reporting is the change most needed before CRISPR-based editing reaches children.
